| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |